Compare BridgeBio Pharma Inc (BBIO) vs Invesco DB Commodity Index Tracking Fund (DBC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Invesco DB Commodity Index Tracking Fund — how do they compare? BridgeBio Pharma Inc trades at $84.09 (market cap $16.27B), while Invesco DB Commodity Index Tracking Fund trades at $28.98. The key difference: BridgeBio Pharma Inc is trading nearer its 52-week high, Invesco DB Commodity Index Tracking Fund nearer its low. Which is the better fit depends on your goals.
| BBIO | DBC | |
|---|---|---|
Market Cap | $16.27B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $90.17 | $31.69 |
52-Week Low | $44.81 | $21.62 |
Enterprise Value | $17.82B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Invesco DB Commodity Index Tracking Fund
DBC is a diversified commodity ETF that tracks the DBIQ Optimum Yield Diversified Commodity Index. It invests in futures contracts for 14 heavily traded commodities, including crude oil, gold, and corn, while optimizing for yield and roll costs.
Read more on DBC →
